ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR Convergence 2020

Abstract Number: 1095

Avascular Necrosis in the Hopkins Myositis Cohort: A Single Center Experience

Khalil Bourji1, Christopher Mecoli2, Julie Paik3, Jemima Albayda3, Eleni Tiniakou3, William Kelly3, Thomas E Lloyd3, Andrew Mammen4 and Lisa Christopher-Stine3, 1Wayne State University/Henry Ford Hospital, Dearborn, MI, 2Johns Hopkins University School of Medicine, Baltimore, MD, 3Johns Hopkins University, Baltimore, MD, 4NIH, Bethesda, MD

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR Convergence 2020

Keywords: Myositis, Work Force

Session Information

Date: Sunday, November 8, 2020

Title: Muscle Biology, Myositis & Myopathies Poster

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: To assess the prevalence of avascular necrosis (AVN) in a large cohort of patients with idiopathic inflammatory myopathies (IIM) and define the major associated risk factors.

Methods: We retrospectively reviewed the electronic medical records of all patients with a definitive diagnosis of IIM in our cohort, querying for keywords (“avascular necrosis”, “AVN”, “osteonecrosis”). Pertinent demographic, clinical (including major risk factors for AVN), serologic and imaging data were collected. A matched group of patients without AVN was then selected for comparison (matched for sex, age at IIM diagnosis ± 2 years, and duration of IIM ± 1 year).

Results: A total of 1680 patients were diagnosed with IIM between 2003 and 2017. Fifty-three patients developed AVN, with a global prevalence of 3.1% (53/1680). Musculoskeletal magnetic resonance imaging (MSK MRI) was available for 1085 patients and AVN was present in 48 patients, with a relative prevalence of 4.4% (48/1085). The majority of patients were Caucasian females (57%) with a mean age at diagnosis of 44.512.4 years. 59% had dermatomyositis (DM), 28% had polymyositis (PM). The median time from diagnosis of IIM to diagnosis of AVN was 46 months. Only 18 % were symptomatic. Hip joint was involved in 77%, Knee joint in 16% and Shoulder joint in 7%. A history of alcohol use was the only risk factor that was statistically associated with AVN (36% vs 13%; OR=3.98, CI [1.31-12.0], p=0.01). Corticosteroid use was not associated with an increased risk of AVN.

Conclusion: Although mostly asymptomatic, the global prevalence of AVN in IIM was 3.1% but the prevalence on MSK MRI was 4.4% and alcohol use was the only risk factor for AVN development.


Disclosure: K. Bourji, None; C. Mecoli, None; J. Paik, None; J. Albayda, None; E. Tiniakou, None; W. Kelly, None; T. Lloyd, None; A. Mammen, None; L. Christopher-Stine, None.

To cite this abstract in AMA style:

Bourji K, Mecoli C, Paik J, Albayda J, Tiniakou E, Kelly W, Lloyd T, Mammen A, Christopher-Stine L. Avascular Necrosis in the Hopkins Myositis Cohort: A Single Center Experience [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/avascular-necrosis-in-the-hopkins-myositis-cohort-a-single-center-experience/. Accessed .

ACR Meeting Abstracts - https://acrabstracts.org/abstract/avascular-necrosis-in-the-hopkins-myositis-cohort-a-single-center-experience/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology